Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes by Can Huang, Yufang Ding, Zhen Chen, Lijun Wu, Wei Wei, Cheng Zhao, Min Yang, Shudian Lin, Qian Wang, Xinping Tian, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng

“…Future ASCVD events were defined as new-onset myocardial infarction, stroke, artery revascularization, or cardiovascular death. …”
Get full text

Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome by Lingmei Li, Ce Cao, Hao Guo, Li Lin, Lei Li, Yehao Zhang, Gaojie Xin, Zixin Liu, Shujuan Xu, Xiao Han, Qiong Zhang, Jianhua Fu

“…Results In vivo, compared with sham group, the percentage of myocardial infarction area was increased and myocardial tissue arrangement was disordered in I/R group. …”
Get full text

Differential Prognosis of True Bifurcation Lesions According to Left Main Versus Non–Left Main Location and Treatment Strategy by Ki Hong Choi, Chang‐Wook Nam, Francesco Bruno, Yun‐Kyeong Cho, Leonardo De Luca, Jeehoon Kang, Alessio Mattesini, Young Bin Song, Alessandra Truffa, Hyo‐Soo Kim, Wojciech Wańha, Woo Jung Chun, Sebastiano Gili, Gerard Helft, Seung Hwan Han, Bernardo Cortese, Cheol Hyun Lee, Javier Escaned, Hyuck‐Jun Yoon, Alaide Chieffo, Joo‐Yong Hahn, Guglielmo Gallone, Seung‐Hyuk Choi, Gaetano De Ferrari, Bon‐Kwon Koo, Giorgio Quadri, Seung‐Ho Hur, Fabrizio D'Ascenzo, Hyeon‐Cheol Gwon, Ovidio de Filippo

“…The primary end point was major adverse cardiac events (MACEs; composite of all‐cause death, myocardial infarction, target lesion revascularization, and stent thrombosis) at 800 days. …”
Get full text

Percutaneous coronary intervention vs. medical therapy in patients on dialysis with coronary artery disease in China by Enmin Xie, Yaxin Wu, Zixiang Ye, Yong He, Hesong Zeng, Jianfang Luo, Mulei Chen, Wenyue Pang, Yanmin Xu, Chuanyu Gao, Xiaogang Guo, Lin Cai, Qingwei Ji, Yining Yang, Di Wu, Yiqiang Yuan, Jing Wan, Yuliang Ma, Jun Zhang, Zhimin Du, Qing Yang, Jinsong Cheng, Chunhua Ding, Xiang Ma, Chunlin Yin, Zeyuan Fan, Qiang Tang, Yue Li, Lihua Sun, Chengzhi Lu, Jufang Chi, Zhuhua Yao, Yanxiang Gao, Changan Yu, Jingyi Ren, Jingang Zheng, Rongman Jia

“…The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. Secondary outcomes included all-cause death, the individual components of MACE, and Bleeding Academic Research Consortium criteria types 2, 3, or 5 bleeding. …”
Get full text

Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio by Daixin Ding, PhD, Jinlong Zhang, MD, PhD, Peng Wu, PhD, Zhiqing Wang, MD, PhD, Huiping Shi, MSc, Wei Yu, PhD, Xinyang Hu, MD, PhD, Jeehoon Kang, MD, Joo-Yong Hahn, MD, Chang-Wook Nam, MD, Joon-Hyung Doh, MD, Bong-Ki Lee, MD, Weon Kim, MD, Jinyu Huang, MD, Fan Jiang, MD, Hao Zhou, MD, Peng Chen, MD, Lijiang Tang, MD, Wenbing Jiang, MD, Xiaomin Chen, MD, Wenming He, MD, Sung Gyun Ahn, MD, Myeong-Ho Yoon, MD, Ung Kim, MD, You-Jeong Ki, MD, Eun-Seok Shin, MD, Seung-Jea Tahk, MD, Jun Pu, MD, William Wijns, MD, PhD, Jian’an Wang, MD, PhD, Bon-Kwon Koo, MD, PhD, Shengxian Tu, PhD

“…The primary endpoint was 2-year target vessel failure, including cardiac death, target vessel myocardial infarction, and target vessel revascularization. …”
Get full text

Clinical features and long-term outcomes in patients under 35 years with coronary artery disease: Nested case–control study by Pablo Juan-Salvadores, Dahyr Olivas-Medina, Luis Mariano de la Torre Fonseca, Cesar Veiga, Silvia Campanioni, Francisco Caamaño Isorna, Andrés Iñiguez Romo, Víctor Alfonso Jiménez Díaz

“…Conclusion: Patients aged ≤35 exhibited a poor long-term prognosis, with a high risk of new revascularization and acute myocardial infarction during the follow-up period. Focusing on preventive measures can have a significant impact on overall prognosis. …”
Get full text

Risk factors affecting progression and course of primary open-angle glaucoma in patients with different disease stages (multicenter study) by N.E. Fomin, P.Ch. Zavadskiy, A.V. Kuroyedov, A.V. Seleznev, Z.M. Nagornova, D.A. Baryshnikova, R.V. Avdeev, A.M. Getmanova, I.A. Glushnev, A.A. Gusarevich, D.A. Dorofeev, S.V. Kosmynina, O.S. Myakonkaya, N.A. Rebenok, Yu.I. Razhko, I.I. Semenova, T.V. Chernyakova

“…Moreover, PEX, PDS, DED, CHD, prior myocardial infarction, and disability resulting from a general illness are additional factors determining POAG resistance to treatment.…”
Get full text

Results of thrombolytic treatment with recombinant streptokinase in elderly and non elderly patients. by René Tomás Manso Fernández, Francisco Valladares Carvajal, Claudio González Rodríguez., Marcos D. Iraola Ferrer

“…<strong>Objective</strong>: To offer the precise results with recombinant sterptokinase in elder and non-elder patients with an acute myocardial infarct. <strong>Method</strong>: prospective observational study of 325 patients admitted with a diagnosis of an acute myocardial infarct at the ¨Dr. …”
Get full text

Biventricular Impella (Bi-Pella) in Refractory Cardiogenic Shock: The First Case from the Middle East by Abdulaziz Almejren, Abdullah Alenezi

“…We describe here the successful use of percutaneous biventricular Impella (Bi-Pella) for cardiogenic shock secondary to acute biventricular myocardial infarctions (AMI-CS), as guided by parameters such as mixed venous oxygen saturation (SvO2), pulmonary artery pulsatility index (PAPi), central venous pressure (CVP), and cardiac power output (CPO). …”
Get full text

Successful pericardiotomy with drainage of the pericardial cavity in case of multimorbid patient by N.M. Seredyuk, A.V. Sudus, I.M. Budzan, S.M. Hrychynyuk, V.В. Tomyn, N.V. Rohiv, M.V. Bielinskyi, A.Ya. Vasylyshyn

“…Multimorbidity of the patient included combination of causal diseases (atherosclerosis, coronary artery atherotrombosis), a number of complicated conditions (two myocardial infarctions, left ventricular aneurysm, cardiac tamponade, acute and chronic heart failure), competitive diseases (peptic ulcer, pancreatitis, obesity, umbilical hernia). …”
Get full text

Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure by Lee R. Goldberg, Ana Jorbenadze, Tamaz Shaburishvilli, Michael J. Mirro, Marat Fudim, Michel Zuber, Simon F. Stämpfli, Felix C. Tanner, Paul Erne, John G. Cleland

“…We describe, in a man with a history of myocardial infarctions resulting in heart failure and persistent New York Heart Association Class III symptoms despite standard therapies, the successful implantation of SDS resulting in improved quality of life, N‐terminal pro brain natriuretic peptide, cardiac function, and exercise tolerance through 12 months of follow‐up. …”
Get full text

Vascular Endothelial Cell Function in Catastrophic Antiphospholipid Syndrome: A Case Report and Review of the Literature by B. Routy, T. Huynh, R. Fraser, C. Séguin

“…Herein, we present a case of a 79-year-old male who presented with a myocardial infarct and renal failure secondary to CAPS following a splenectomy for immune thrombocytopenia. …”
Get full text

Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke? by Zain Kulairi, Nisha Deol, Renee Tolly, Rohan Manocha, Maliha Naseer

“…Adverse events due to this procedure occur at low rates and include stroke, arrhythmia, and myocardial infarctions. Due to the high volume of procedures there are a growing number of adverse events. …”
Get full text

Unique Findings and Novel Treatment Strategy of a Giant Coronary Artery Aneurysm Associated with a Significant Pericardial Effusion by Osayi Lawani, Rick Ganim

“…A popular treatment option for these aneurysms is polytetrafluoroethylene-covered stents; they have been favorable with obtaining a high percentage of procedural success rates in aneurysms not associated with myocardial infarctions. In this paper, we present a case of a giant coronary artery aneurysm located in the left circumflex coronary artery that was complicated by a pericardial effusion. …”
Get full text

Patent Foramen Ovale and Closure Technique with the Amplatzer Occluder by Bernhard Meier

“…They are outweighed by the supposedly prevented events of paradoxical embolisms, such as stroke, transient ischemic attacks, myocardial infarctions, or other systemic embolisms. Medical treatment with perhaps the exception of lifelong oral anticoagulation provides less protection. …”
Get full text

Cardioprotective Effect of Nec-1 in Rats Subjected to MI/R: Downregulation of Autophagy-Like Cell Death by Liang Wang, Xuebai Lv, Jue Tian, Xiaoliang Wang, Ye Wu, Hui Rong Liu

“…The present study investigated the effect of Nec-1 on myocardial infarct size, necroptosis, and cardiac functional recovery in rats subjected to myocardial ischemia-reperfusion (MI/R 30 min/12, 24, 48, and 72 h). …”
Get full text

Short-Term Cardiac and Noncardiac Mortality Following Liver Transplantation by Mackram F. Eleid, R. Todd Hurst, Hugo E. Vargas, Jorge Rakela, David C. Mulligan, Christopher P. Appleton

“…Acute cardiac events occurred in 26 patients (6.6%), including 13 arrhythmias (50%), 7 new onset heart failures (27%), and 6 myocardial infarctions (23%). Twelve of 13 intraoperative events were arrhythmias (92%) including two of three cardiac deaths. …”
Get full text

The Tao of Hematopoietic Stem Cells: Toward a Unified Theory of Tissue Regeneration by Kevin D. Bunting, Robert G. Hawley

“…Preclinical amelioration of liver disease and myocardial infarcts by HSC-enriched bone marrow cell populations raises the possibility that HSC transplants have the potential to provide therapeutic benefit for a wide variety of diseases. …”
Get full text

Caffeoylquinic Acid Derivatives Extract of Erigeron multiradiatus Alleviated Acute Myocardial Ischemia Reperfusion Injury in Rats through Inhibiting NF-KappaB and JNK Activations by Zhifeng Zhang, Yuan Liu, Xuecong Ren, Hua Zhou, Kaishun Wang, Hao Zhang, Pei Luo

“…AE administration (10, 20, and 40 mg/kg) inhibited I/R-induced injury as indicated by decreasing myocardial infarct size, reducing of CK and LDH activities, and preventing ST-segment depression in dose-dependent manner. …”
Get full text

Biophysics and electrophysiology of pulsed field ablation in normal and infarcted porcine cardiac ventricular tissue by Damijan Miklavčič, Atul Verma, Philippa R. P. Krahn, Jernej Štublar, Bor Kos, Terenz Escartin, Peter Lombergar, Nicolas Coulombe, Maria Terricabras, Tomaž Jarm, Matej Kranjc, Jennifer Barry, Lars Mattison, Nicole Kirchhof, Daniel C. Sigg, Mark Stewart, Graham Wright

“…In this study, we used an in vivo swine model (10 healthy and 5 with chronic myocardial infarct) for ventricular PFA, collecting intracardiac electrograms, electro-anatomical maps, native T1-weighted and late gadolinium enhancement MRI, gross pathology, and histology. …”
Get full text